AHR and melanoma: To date, targeted cell-type specific chromatin interactions have not been evaluated across all genome-wide significant melanoma risk loci, but the utility of this approach has been demonstrated in establishing AHR as a functionally-validated ultraviolet B (UVB)-responsive melanoma susceptibility gene47.